Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome.

In an open randomized multicenter comparative study, we evaluated the safety and efficacy of cefepime (CP; 2.0 g given intravenously every 12 h) and ceftazidime (CZ; 2.0 g given intravenously every 8 h) as initial treatment for adult patients with suspected serious bacterial infections. A total of 1...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Kieft, H, Hoepelman, A I, Rozenberg-Arska, M, Branger, J M, Voskuil, J H, Geers, A B, Kluyver, M, Hart, H C, Poest-Clement, E, van Beugen, L
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1994
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284473/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8203833/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.3.415
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki